Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.
The 2021 Biotech Six Pack: Stocks We Expect to Double!
These are ideas #3 and #4 for the 'Biotech...
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants
We were having cocktails at...
What We’re Watching.
“Biotech, Beverages and Bears - Oh My!”
— Daniel K. McMahon
Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.
Contactless Health Screening
Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological...
Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).
Clorox shares have soared more than 54% for the year to date, an increase of $11.5 billion to $29.5 billion.
FDA Approval for Provention Bio (PRVB).
Re-cork the Champagne!
We were contemplating (dreaming) about an opening price over $12, and then a drift up...
Adding Provention Bio (PRVB) $4.60 to 2022 Biotech Watch List.
This is in our 'Stocks we Hope to Double' Watch List.
LIVE QUOTE
Revive Therapeutics Gains 25% on Positive FDA Comments.
The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and...
Newsletter: Institutional Analyst. And Yes, We Have Another Double.
1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....
Qiming Venture Partners Raises $1.1 Billion Fund VII
Qiming USA Portfolio
The vast majority of Qiming's capital comes from a prestigious group of endowments, foundations, family offices,...
Latest article
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
Major Mpox Outbreak in the Democratic Republic of Congo.
As Reported in NPR's Gates and Soda
Major Mpox Outbreak in the Democratic Republic of Congo is a...
Mpox Infections Rise to Almost Double Last Year’s Numbers.
The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...
